NASDAQ:CNSP | Free Cash Flow | CNS Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.65M$6,179.00-$4.65M
2025-12-31-$3.05M
2025-03-31-$3.24M$0.00-$3.24M
2024-12-31-$5.47M$4,188.00-$5.48M
2024-03-31-$3.19M
2023-12-31-$2.54M$2,157.00-$2.54M
2023-03-31-$4.82M
2022-12-31-$2.31M-$1.00-$2.31M
2022-03-31-$3.08M$0.00-$3.08M
2021-12-31-$3.24M$2,076.00-$3.24M
2021-03-31-$3.31M$3,672.00-$3.31M
2020-12-31-$1.45M$0.00-$1.45M
2020-03-31-$1.86M$6,410.00-$1.86M
2019-12-31-$2.48M$11,743.00-$2.49M
2019-03-31-$82,688.00$0.00-$82,688.00
2018-12-31-$159,493.00$0.00-$159,493.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$13.81M$18,175.00-$13.83M
2024-12-31-$17.11M$4,188.00-$17.12M
2023-12-31-$14.14M$3,901.00-$14.14M
2022-12-31-$10.56M$4,422.00-$10.56M
2021-12-31-$13.54M$5,748.00-$13.54M
2020-12-31-$7.32M$17,945.00-$7.34M
2019-12-31-$3.55M$20,120.00-$3.57M
2018-12-31-$716,385.00$0.00-$716,385.00